Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management-Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine

Cancer causes many deaths worldwide each year, especially due to tumor heterogeneity leading to disease progression and treatment failure. Targeted treatment of heterogeneous population of cells - cancer stem cells is still an issue in protecting affected individuals against associated multidrug res...

Full description

Saved in:
Bibliographic Details
Main Authors: Lenka Koklesova (Author), Jana Jakubikova (Author), Dana Cholujova (Author), Marek Samec (Author), Alena Mazurakova (Author), Miroslava Šudomová (Author), Martin Pec (Author), Sherif T. S. Hassan (Author), Kamil Biringer (Author), Dietrich Büsselberg (Author), Tatiana Hurtova (Author), Olga Golubnitschaja (Author), Peter Kubatka (Author)
Format: Book
Published: Frontiers Media S.A., 2023-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_acb3eb4df5d04e828d51a0d3755618d1
042 |a dc 
100 1 0 |a Lenka Koklesova  |e author 
700 1 0 |a Jana Jakubikova  |e author 
700 1 0 |a Jana Jakubikova  |e author 
700 1 0 |a Dana Cholujova  |e author 
700 1 0 |a Dana Cholujova  |e author 
700 1 0 |a Marek Samec  |e author 
700 1 0 |a Alena Mazurakova  |e author 
700 1 0 |a Miroslava Šudomová  |e author 
700 1 0 |a Martin Pec  |e author 
700 1 0 |a Sherif T. S. Hassan  |e author 
700 1 0 |a Kamil Biringer  |e author 
700 1 0 |a Dietrich Büsselberg  |e author 
700 1 0 |a Tatiana Hurtova  |e author 
700 1 0 |a Olga Golubnitschaja  |e author 
700 1 0 |a Peter Kubatka  |e author 
245 0 0 |a Phytochemical-based nanodrugs going beyond the state-of-the-art in cancer management-Targeting cancer stem cells in the framework of predictive, preventive, personalized medicine 
260 |b Frontiers Media S.A.,   |c 2023-03-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2023.1121950 
520 |a Cancer causes many deaths worldwide each year, especially due to tumor heterogeneity leading to disease progression and treatment failure. Targeted treatment of heterogeneous population of cells - cancer stem cells is still an issue in protecting affected individuals against associated multidrug resistance and disease progression. Nanotherapeutic agents have the potential to go beyond state-of-the-art approaches in overall cancer management. Specially assembled nanoparticles act as carriers for targeted drug delivery. Several nanodrugs have already been approved by the US Food and Drug Administration (FDA) for treating different cancer types. Phytochemicals isolated from plants demonstrate considerable potential for nanomedical applications in oncology thanks to their antioxidant, anti-inflammatory, anti-proliferative, and other health benefits. Phytochemical-based NPs can enhance anticancer therapeutic effects, improve cellular uptake of therapeutic agents, and mitigate the side effects of toxic anticancer treatments. Per evidence, phytochemical-based NPs can specifically target CSCs decreasing risks of tumor relapse and metastatic disease manifestation. Therefore, this review focuses on current outlook of phytochemical-based NPs and their potential targeting CSCs in cancer research studies and their consideration in the framework of predictive, preventive, and personalized medicine (3PM). 
546 |a EN 
690 |a nanomedicine 
690 |a nanoparticles 
690 |a phytochemicals 
690 |a plant-derived foods 
690 |a cancer stem cells therapy 
690 |a predictive preventive personalized medicine 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 14 (2023) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2023.1121950/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/acb3eb4df5d04e828d51a0d3755618d1  |z Connect to this object online.